M. Gnant

Bisphosphonates in the adjuvant treatment of early breast cancer (2009)

Gnant, M

No abstract available.

Third consensus on medical treatment of metastatic breast cancer (2009)

Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., ...

Background: Treatment options for patients with metastatic breast cancer (MBC) include a rapidly expanding repertoire of medical, surgical and supportive care measures. Design: To provide timely and...

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial (2008)

Pestalozzi, B. C., Francis, P., Quinaux, E., Dolci, S., Azambuja, E., Gelber, R. D., ...

Background: Breast cancer central nervous system (CNS) metastases are an increasingly important problem because of high CNS relapse rates in patients treated with trastuzumab and/or taxanes. Patients...

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel (2008)

Aapro, M., Abrahamsson, P. A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., ...

Bisphosphonates (BP) prevent, reduce, and delay cancer-related skeletal complications in patients, and have substantially decreased the prevalence of such events since their introduction. Today, a...

Second consensus on medical treatment of metastatic breast cancer (2007)

BESLIJA, S, BONNETERRE, J, BURSTEIN, H, Cocquyt, Veronique, GNANT, M, GOODWIN, P, ...

Second consensus on medical treatment of metastatic breast cancer (2007)

Beslija, S, Bonneterre, J, Burstein, H, Cocquyt, V, Gnant, M, Goodwin, P, ...

The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.

Second consensus on medical treatment of metastatic breast cancer (2006)

Beslija, S., Bonneterre, J., Burstein, H., Cocquyt, V., Gnant, M., Goodwin, P., ...

The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.

Second consensus on medical treatment of metastatic breast cancer (2006)

Beslija, S., Bonneterre, J., Burstein, H., Cocquyt, V., Gnant, M., Goodwin, P., ...

The present consensus manuscript defines evidence-based recommendations for state-of-the-art treatment of metastatic breast cancer depending on disease-associated and biologic variables.

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials (2005)

ABE, O, ABE, R, ENOMOTO, K, KIKUCHI, K, KOYAMA, H, MASUDA, H, ...

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005)

ABE, O, ABE, R, ENOMOTO, K, KIKUCHI, K, KOYAMA, H, MASUDA, H, ...

Abstract (1992)

Strohscheer, I., Kleinert, R., Westphal, C., Schüller, J., Werner, K., Anders, O., ...

Peer Reviewed

Haemophilus parainfluenzae Liver Abscess after Successful Liver Transplantation

Friedl, J., Stift, A., Berlakovich, G. A., Taucher, S., Gnant, M., Steininger, R., ...

Haemophilus parainfluenzae was isolated from a bile specimen and from an aspirate of a liver abscess in a 58-year-old liver-transplanted woman that was indicative of an invasion of the graft by an...

Haemophilus parainfluenzae Liver Abscess after Successful Liver Transplantation

Friedl, J., Stift, A., Berlakovich, G. A., Taucher, S., Gnant, M., Steininger, R., ...

Haemophilus parainfluenzae was isolated from a bile specimen and from an aspirate of a liver abscess in a 58-year-old liver-transplanted woman that was indicative of an invasion of the graft by an...

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

Fiegl, M., Tueni, C., Schenk, T., Jakesz, R., Gnant, M., Reiner, A., ...

The occurrence of aberrations involving chromosomes 11 and 17 in malignant tissues of breast cancer patients has not yet been studied systematically. Using fluorescence in situ hybridisation (FISH)...

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer

Schippinger, W, Samonigg, H, Schaberl-Moser, R, Greil, R, Thödtmann, R, Tschmelitsch, J, ...

The purpose of this trial was to investigate the efficacy of adjuvant chemotherapy with 5-fluorouracil (5-FU) and leucovorin (LV) in stage II colon cancer. Patients with stage II colon cancer were...

A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer

Schippinger, W, Jagoditsch, M, Sorré, C, Gnant, M, Steger, G, Hausmaninger, H, ...

The purpose of this trial was to examine the efficacy of the addition of levamisole (LEV) or interferon alfa (IFN) to an adjuvant chemotherapy with 5-fluorouracil (5-FU) in patients with stage III...

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma

Schmidinger, M, Wenzel, C, Locker, G J, Muehlbacher, F, Steininger, R, Gnant, M, ...

We performed a pilot-study on pegylated liposomal doxorubicin (PLD) for advanced hepatocellular carcinoma. Seventeen patients received 40 mg/m2 PLD intravenously every 4 weeks. A clinical benefit...

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial

Pestalozzi, B. C., Francis, P., Quinaux, E., Dolci, S., Azambuja, E., Gelber, R. D., ...

Background: Breast cancer central nervous system (CNS) metastases are an increasingly important problem because of high CNS relapse rates in patients treated with trastuzumab and/or taxanes.